Cargando…
Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia
OBJECTIVE: To determine whether genetic polymorphisms related to pharmacodynamics with metabolic adverse effects, namely leptin promoter (LEP) rs7799039, leptin receptor rs1137101, dopamine D2 rs4436578, serotonin 5-HT2A rs6313, and serotonin 5-HT2C rs518147 and rs12836771, are associated with hyper...
Autores principales: | Puangpetch, Apichaya, Srisawasdi, Pornpen, Unaharassamee, Weerapon, Jiratjintana, Napa, Vanavanan, Somlak, Punprasit, Suweejuk, Na Nakorn, Chalitpon, Sukasem, Chonlaphat, Kroll, Martin H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689662/ https://www.ncbi.nlm.nih.gov/pubmed/31496784 http://dx.doi.org/10.2147/PGPM.S210770 |
Ejemplares similares
-
Associations of the SREBF2 Gene and INSIG2 Polymorphisms with Obesity and Dyslipidemia in Thai Psychotic Disorder Patients Treated with Risperidone
por: Vanwong, Natchaya, et al.
Publicado: (2021) -
Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin
por: Srisawasdi, Pornpen, et al.
Publicado: (2021) -
Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population
por: Na nakorn, Chalitpon, et al.
Publicado: (2020) -
Hyperuricemia in Children and Adolescents with Autism Spectrum Disorder Treated with Risperidone: The Risk Factors for Metabolic Adverse Effects
por: Vanwong, Natchaya, et al.
Publicado: (2017) -
Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
por: Hongkaew, Yaowaluck, et al.
Publicado: (2015)